HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

YM 158

a dual antagonist for LTD(4) and TXA(2) receptors; structure in first source
Also Known As:
3-(4-tert-butylthiazol-2-yl)methoxy)-5'-(3-(4-chlorobenzenesulfonyl)propyl-2'-(1H-tetrazol-5-ylmethoxy)benzanilide monosodium salt monohydrate; YM-158; YM158
Networked: 3 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Arakida, Y: 2 articles (05/2000 - 04/2000)
2. Honda, K: 2 articles (05/2000 - 04/2000)
3. Miyata, K: 2 articles (05/2000 - 04/2000)
4. Morio, H: 2 articles (05/2000 - 04/2000)
5. Ohga, K: 2 articles (05/2000 - 04/2000)
6. Okada, Y: 2 articles (05/2000 - 04/2000)
7. Suwa, K: 2 articles (05/2000 - 04/2000)
8. Yamada, T: 2 articles (05/2000 - 04/2000)
9. Yokota, M: 2 articles (05/2000 - 04/2000)
10. Benoit, Patricia: 1 article (01/2002)

Related Diseases

1. Asthma (Bronchial Asthma)
2. Respiratory Hypersensitivity

Related Drugs and Biologics

1. Leukotriene D4
2. Thromboxanes
3. Salts
4. Lipids
5. seratrodast
6. pranlukast
7. benzanilide